These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7637668)

  • 21. [Current status of methotrexate].
    Fiehn C
    Z Rheumatol; 2011 Feb; 70(2):99-100. PubMed ID: 21312022
    [No Abstract]   [Full Text] [Related]  

  • 22. [Methotrexate in the therapy of psoriasis].
    Stáva Z
    Cesk Dermatol; 1973 Jun; 48(3):203-6. PubMed ID: 4725888
    [No Abstract]   [Full Text] [Related]  

  • 23. Folate supplementation during methotrexate therapy for patients with psoriasis.
    Strober BE; Menon K
    J Am Acad Dermatol; 2005 Oct; 53(4):652-9. PubMed ID: 16198787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACP Journal Club. Review: Methotrexate does not increase risk for lung disease in psoriasis, psoriatic arthritis, or IBD.
    Smith MD
    Ann Intern Med; 2015 Jul; 163(2):JC7. PubMed ID: 26192587
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of methotrexate in psoriasis].
    Novotný F
    Cesk Dermatol; 1973 Oct; 48(5):301-5. PubMed ID: 4586960
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological therapies in autoimmune chronic inflammatory diseases (ACIDs).
    Ferraccioli GF; Gremese E
    Eur Rev Med Pharmacol Sci; 2006; 10(1):37-40. PubMed ID: 16494110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Methotrexate therapy in psoriasis].
    Bournerias I
    Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon.
    Nissen MJ; Fontanges E; Allam Y; Zoulim F; Trépo C; Miossec P
    Rheumatology (Oxford); 2005 Aug; 44(8):1016-20. PubMed ID: 15855185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
    Rogler G
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1917-21. PubMed ID: 18785084
    [No Abstract]   [Full Text] [Related]  

  • 30. [Letter: D penicillamine and psoriatic polyarthritis].
    Roux H; Maestracci D; Recordier AM
    Nouv Presse Med; 1975 Apr; 4(15):1133. PubMed ID: 1094415
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of psoriasis with methotrexate].
    Enderer K
    Z Hautkr; 1983 May; 58(9):619-20. PubMed ID: 6868732
    [No Abstract]   [Full Text] [Related]  

  • 32. [Exploring new therapeutic approaches to the treatment of inflammatory disorders--lipoxins].
    Jarmakowska K; Kuna P
    Pol Merkur Lekarski; 2005 May; 18(107):578-80. PubMed ID: 16161960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic therapy of psoriasis using methotrexate.
    Smith KC
    Skin Therapy Lett; 2000; 6(3):1-2; 5. PubMed ID: 11176041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human low-dosage parenteral methotrexate therapy. A controlled toxicity study.
    Wright ET; Wolborsky M; Hamer EE
    Arch Dermatol; 1966 Jun; 93(6):731-6. PubMed ID: 4222659
    [No Abstract]   [Full Text] [Related]  

  • 35. Risks of combining immunosuppressive and biological treatments in inflammatory bowel disease.
    Roblin X; Phelip JM
    Arch Intern Med; 2008 Mar; 168(6):667; author reply 667-8. PubMed ID: 18362263
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk of hepatitis B virus reactivation in patients treated with anti-TNFα agents for immune-mediated inflammatory diseases.
    Pereira R; Raposo I; Nery F; Torres T
    Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):285-287. PubMed ID: 29054331
    [No Abstract]   [Full Text] [Related]  

  • 37. [Progress in dermatology, 1973].
    De Bersaques J; Kint A
    Arch Belg Dermatol; 1973; 29(4):369-74. PubMed ID: 4605890
    [No Abstract]   [Full Text] [Related]  

  • 38. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
    Aydin F; Canturk T; Senturk N; Turanli AY
    Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
    Dadlani C; Orlow SJ
    J Am Acad Dermatol; 2005 Feb; 52(2):316-40. PubMed ID: 15692480
    [No Abstract]   [Full Text] [Related]  

  • 40. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
    Vroom F; van Roon EN; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):52-61. PubMed ID: 17948319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.